|
|
1.
|
Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients. MedStar authors:
Citation: - Journal of the American College of Cardiology. 66(5):524-31, 2015 Aug 4.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Blasco-Colmenares E, Butcher B, Cheng A, Dickfeld T, Eldadah Z, Ellenbogen KA, Guallar E, Marine JE, Nauffal V, Norgard S, Tomaselli GF, Zhang Y
|
|
|
2.
|
Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD). MedStar authors:
Citation: - Circulation: Arrhythmia and Electrophysiology. 7(6):1084-91, 2014 Dec.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Observational Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Blasco-Colmenares E, Butcher B, Cheng A, Dalal D, Dickfeld T, Eldadah Z, Ellenbogen KA, Guallar E, Marine JE, Norgard S, Spragg DD, Tomaselli GF, Zhang Y
|
